Notable Analyst Rating Changes 12/4: (INFI) (MBLY) (CSX) Upgraded; (DISH) (RIO) (WMT) Downgraded
Tweet Send to a Friend
UPGRADES
Credit Suisse raises Infinity Pharmaceutical (Nasdaq: INFI) from Neutral to Outperform and moves its price target from $20 to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Credit Suisse raises Infinity Pharmaceutical (Nasdaq: INFI) from Neutral to Outperform and moves its price target from $20 to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
